STOCK TITAN

Xebra Brands Stock Price, News & Analysis

XBRAF OTC

Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.

Xebra Brands Ltd. (XBRAF) maintains its position as Mexico's pioneering fully licensed cannabis company, specializing in COFEPRIS-approved CBD products and regulated cultivation operations. This news hub provides investors with essential updates on regulatory milestones, product developments, and strategic initiatives shaping the company's trajectory in the evolving cannabis sector.

Access real-time updates on XBRAF's compliance achievements, manufacturing partnerships, and market expansion efforts. Our curated news collection covers critical developments including new product authorizations, supply chain enhancements, and regulatory strategy adjustments specific to Mexico's cannabis framework.

Key coverage areas include COFEPRIS approval updates, wellness product launches, cultivation license expansions, and strategic collaborations with industry partners. Each update is verified for regulatory accuracy and operational relevance to maintain investor confidence in this complex market environment.

Bookmark this page for streamlined access to Xebra Brands' official communications and third-party analyses. Monitor the company's progress in navigating Mexico's cannabis regulations while maintaining its first-mover advantage in authorized CBD product distribution.

News
Rhea-AI Summary

Xebra Brands (OTC:XBRAF) has provided an update regarding its previously announced Management Cease Trade Order (MCTO). The company failed to file its required Annual Financial Filings for the year ended February 28, 2025, by the June 30, 2025 deadline due to liquidity constraints and recent management changes.

The company expects to complete and file the required documents by August 29, 2025. Until then, Xebra will issue bi-weekly default status reports and confirms no material business developments have occurred since the last disclosure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Xebra Brands (OTCQB:XBRAF), an international cannabis company, has provided an update regarding its previously announced Management Cease Trade Order (MCTO). The company failed to file its required Annual Financial Filings for the year ended February 28, 2025 by the June 30, 2025 deadline.

The delay is attributed to liquidity constraints and recent management changes. Xebra expects to complete and file the required documents by August 29, 2025. During this period, the company will issue bi-weekly default status reports and confirms no undisclosed material business developments have occurred.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Xebra Brands (OTCQB:XBRAF) has announced three significant developments: First, the company has terminated its non-binding Letter of Intent to acquire BSK Holdings Inc., originally announced on April 24th, 2025, after determining it wasn't in the company's best interest following due diligence.

Despite the terminated acquisition, Xebra will maintain its partnership with BSK to launch its ELEMENTS™ CBD product line in the United States. Additionally, the company has disclosed a delay in filing its annual financial statements for the year ended February 28, 2025, resulting in a voluntary Management Cease Trade Order (MCTO).

Lastly, Xebra has secured a C$110,000 loan from an existing shareholder at 10% annual interest, maturing in one year, to support working capital needs and complete the delayed annual audit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.29%
Tags
Rhea-AI Summary
Xebra Brands issued a correction regarding their earlier press release about a management cease trade order (MCTO). The company clarified that they have only applied for, but not yet received, the MCTO from the British Columbia Securities Commission regarding their delayed fiscal year 2025 financial statements due June 30, 2025. Additionally, CFO Omar Garcia and director Keith Dolo have resigned to pursue other opportunities, with CEO Rodrigo Gallardo stepping in as interim CFO. The company also announced the extension of 13,311,731 warrants with a $0.10 exercise price from June 30, 2025 to December 31, 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
none
-
Rhea-AI Summary
Xebra Brands Ltd. (XBRAF) has announced a delay in filing its audited annual financial statements, management's discussion and analysis, and related officer certifications for the fiscal year ended February 28, 2025. The company was unable to meet the June 28, 2025 filing deadline due to recent management changes. In response, Xebra has been granted a management cease trade order (MCTO) by the British Columbia Securities Commission. The company is working with its auditors, Dale Matheson Carr-Hilton LaBonte LLP, and expects to complete the audit by August 29, 2025. Xebra will provide biweekly default status reports until the Annual Filings are submitted and does not anticipate future filing delays following the completion of management changes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
none
-
Rhea-AI Summary

Xebra Brands Ltd. (XBRAF) has announced significant progress in its U.S. commercialization strategy, particularly regarding the upcoming launch of its ELEMENTS™ CBD product line scheduled for Summer 2025. Through its partnership with NF Skin and RT Fulfillment, the company has completed several crucial milestones, including:

- Finalization of product formulations including tinctures, gummies, topicals, and wellness supplements
- Completion of e-commerce planning and FDA compliance activities
- Development of branded packaging and marketing assets
- Integration with RT Fulfillment's logistics infrastructure for nationwide distribution

The initiative represents Xebra's strategic move to diversify its portfolio and generate revenue from the growing U.S. CBD market through both e-commerce and retail channels.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.58%
Tags
none
Rhea-AI Summary

Xebra Brands (XBRA:CSE)(XBRAF:OTCQB) has entered into a non-binding letter of intent to acquire BSK Holdings Inc., a CBD e-commerce company, expected to complete by Q3 2025. BSK has generated over $50M USD in revenue since 2021, with $2.1M in EBIDTA and 62% gross margin.

The acquisition represents approximately 45% of Xebra's share capital, valued at $4.5MM CAD. BSK brings established brands like Keoni and AMMA, along with expertise in scaling cannabis and hemp companies. The deal aims to strengthen Xebra's position in the North American CBD market, particularly in the US and Mexico.

Key transaction highlights include:

  • Creation of a strategic platform for North American growth
  • Enhanced Mexican CBD market penetration
  • Expanded product portfolio combining BSK's brands with Xebra's Elements line
  • Development of e-commerce capabilities for the Mexican market

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12%
Tags
-
Rhea-AI Summary

Xebra Brands (CSE:XBRA)(OTCQB:XBRAF) has signed a Manufacturing and Distribution Agreement with NF Skin and its fulfillment division, RT Fulfillment, dated April 14, 2025. The partnership aims to launch Xebra's ELEMENTS™ CBD product line in the U.S. market.

NF Skin, established in 2003, will provide custom formulation, manufacturing, packaging, and branding services in GMP-certified U.S. facilities. The ELEMENTS™ product line will include tinctures, topicals, gummies, and wellness supplements. RT Fulfillment will manage drop shipping, inventory, and order fulfillment operations.

This collaboration supports Xebra's strategy to expand its presence in the U.S. CBD market and diversify operations across North America.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
none
-
Rhea-AI Summary

Xebra Brands (CSE:XBRA)(OTCQB:XBRAF), the only company legally authorized to cultivate and sell cannabis (-1% THC) in Mexico, has announced a Request for Proposal (RFP) initiative to establish 5-12 agricultural partnerships across Mexico for cannabis cultivation under federal authorization.

The RFP will be open from June 1, 2025 to August 31, 2025, with selected partners to be announced in fall 2025. The company is seeking experienced agricultural companies, landowners, and municipal entities for these partnerships.

The RFP evaluation criteria includes:

  • Land information and infrastructure suitability
  • Legal compliance with COFEPRIS guidelines
  • Operational experience in high-value crop cultivation
  • Business model and investment proposals
  • Environmental sustainability practices
  • Security protocols
  • Implementation readiness

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary

Xebra Brands (XBRAF) has reinforced its North American market strategy following recent U.S. tariff announcements. The company, which holds exclusive authorization to operate in Mexico's cannabis sector, benefits from the USMCA exemption from the new 10% universal U.S. import tariff announced on April 2, 2025.

The company is pursuing two significant initiatives: a landmark agricultural agreement with major shareholder David Ross Macias Diaz for cannabis cultivation in Mexico, and a strategic partnership with BSK to enhance e-commerce presence and facilitate U.S. market entry for its Elements™ product line.

Interim-CEO Rodrigo Gallardo emphasized that recent market developments reinforce their North American strategy, particularly given the protected trade environment under USMCA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.04%
Tags
none

FAQ

What is the current stock price of Xebra Brands (XBRAF)?

The current stock price of Xebra Brands (XBRAF) is $0.0141 as of August 1, 2025.

What is the market cap of Xebra Brands (XBRAF)?

The market cap of Xebra Brands (XBRAF) is approximately 2.6M.
Xebra Brands

OTC:XBRAF

XBRAF Rankings

XBRAF Stock Data

2.63M
68.84M
24.16%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver